FDA approves Novocure device to treat rare lung cancer - MedTech Dive

FDA approves Novocure device to treat rare lung cancer  MedTech Dive

FDA has approved Novocure's tumor treating fields delivery system NovoTTF-100L for use in patients with malignant pleural mesothelioma (MPM). The approval ...



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...